Most supplement logic says more is more. This trial of a pomegranate extract pill called Pomanox pointed the other way. The lower dose, 367 mg, produced the most interesting skin signals, while the 700 mg dose mostly lagged behind it. Before you order a bottle, there's a catch: the study's main goal, shrinking a facial dark spot, did not hit statistical significance.
This page is available in